Browse drugs

…lusions Mdr2-/- mice show a limited response to BAAs (including ursodeoxycholic acid), consistent with humans who have severe loss-of-function ABCB4…

…43%) and Caucasian (39%) patients than in Asian patients (26%). Obeticholic acid was more widely prescribed than bezafibrate in all groups. Asia…

…their findings with respect to genotype-specific treatment with IBATi, ursodeoxycholic acid, or alternative drugs. The aim is to prov…

…k, intestinal failure-associated liver disease, and exposure to ursodeoxycholic acid. Longitudinal analysis revealed that microbial diversity increa…

…ation and highlight that further investigation into the optimal UDCA dosing strategy is warranted.Abstract IDDF2026-ABS-0146 Figure …

…g transient elastography or liver biopsy. All patients received ursodeoxycholic acid (13–15 mg/kg/day), and PHT was managed according to standard cl…

…UDCA), obeticholic acid (OCA), and amongst those switching from bezafibrate (BZF).Results From Dec 2024 to Nov 2025, 54 pts initiated Ela (…

…imit of normal (ULN), and to identify predictors of response to ursodeoxycholic acid (UDCA).Methods We conducted a single-centre retrospective study…

…New Abstract_ Use of Ursodeoxycholic Acid as initial management of multi-morbid or frail patients with ch…

…nor arm were –41.5% (26.7), –41.8% (23.0) and –32.3% (22.3) for elafibranor in the healthy weight, overweight and obese subgroups respectiv…

…2, and 34(29.8%) F3-F4 (severe fibrosis). All patients received ursodeoxycholic acid (UDCA) at 13 mg/kg. Regarding prediction of severe fibrosis, th…

…erval between diagnoses was 3.0 years (IQR 10.25). All received ursodeoxycholic acid with good biochemical response; three (25.0%) developed cirrhos…